Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Assets (2021 - 2025)

LifeStance Health (LFST) has disclosed Assets for 5 consecutive years, with $2.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Assets rose 4.04% to $2.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 billion, a 4.04% increase, with the full-year FY2025 number at $2.2 billion, up 4.04% from a year prior.
  • Assets was $2.2 billion for Q4 2025 at LifeStance Health, up from $2.1 billion in the prior quarter.
  • In the past five years, Assets ranged from a high of $2.2 billion in Q4 2025 to a low of $1.9 billion in Q2 2021.
  • A 5-year average of $2.1 billion and a median of $2.1 billion in 2023 define the central range for Assets.
  • Peak YoY movement for Assets: grew 12.8% in 2022, then decreased 3.09% in 2024.
  • LifeStance Health's Assets stood at $1.9 billion in 2021, then increased by 12.8% to $2.2 billion in 2022, then decreased by 2.94% to $2.1 billion in 2023, then rose by 0.39% to $2.1 billion in 2024, then rose by 4.04% to $2.2 billion in 2025.
  • Per Business Quant, the three most recent readings for LFST's Assets are $2.2 billion (Q4 2025), $2.1 billion (Q3 2025), and $2.1 billion (Q2 2025).